Company Filing History:
Years Active: 2021
Title: Lusi Zhang: Innovator in Glaucoma Treatment
Introduction
Lusi Zhang is a notable inventor based in Hunan, China. He has made significant contributions to the field of medical research, particularly in the treatment of glaucoma. His innovative approach has led to the development of a unique application that addresses a critical health issue.
Latest Patents
Lusi Zhang holds a patent for the "Application of LNCRNAS ENST00000607393 siRNA in preparing preparation for treating glaucoma." This invention clarifies the correlation between the expression level of ENST00000607393 and the calcification of human primary trabecular meshwork cells. The research demonstrates that the expression level of ENST00000607393 can be down-regulated to 46.21% of a control group through siRNA interference. Under specific conditions, this down-regulation significantly decreases the ALP activity in human primary trabecular meshwork cells, thereby reducing the calcification level and offering a potential treatment or prevention method for glaucoma.
Career Highlights
Lusi Zhang is affiliated with The Second Xiangya Hospital of Central South University, where he conducts his research and develops innovative solutions for medical challenges. His work has garnered attention for its potential impact on glaucoma treatment.
Collaborations
Lusi Zhang collaborates with esteemed colleagues, including Bing Jiang and Lili Xie, who contribute to his research efforts and enhance the scope of his projects.
Conclusion
Lusi Zhang's innovative work in the application of siRNA for glaucoma treatment showcases his dedication to advancing medical science. His contributions are paving the way for new therapeutic approaches in the field.